Second Covid-19 Vaccine Shown To Be 95% Effective

Johnson and Johnson vaccine

Johnson and Johnson vaccine

"Filing in the USA represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential", Pfizer CEO Albert Bourla said.

The speedy regulatory assessment comes as many European countries battle fierce new waves with the onset of colder weather, forcing governments to impose new lockdowns over tired populations.

Pfizer and BioNTech expect to produce a total of 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021. The price it agreed for the Pfizer-BioNTech shot is 15.50 euros ($18.34) per dose, less than what the U.S.is paying, the newswire said.

This announcement follows that by U.S. giant Pfizer and Germany's BioNTech last week that their vaccine was found to be more than 90 per cent effective.

Russell Westbrook told Rockets he's uneasy about their accountability and culture
Daryl Morey left for a new challenge in Philly, not long after Mike D'Antoni parted ways with the organization too. He now has three years and more than $132 (AUD$179M) million left on his contract to run.

The announcement had been expected for several days after the companies said that a completed study of trials of the product showed it was 95 percent effective in protecting people from infection.

News from USA drug company Moderna Inc. that its potential COVID-19 vaccine candidate has also been more than 90 per cent effective in clinical trials sent stock markets soaring on Monday, boosting hopes that the global economy may soon fully convalesce and things could get back to normal.

The extraordinary results have sparked euphoria as the unprecedented compression of vaccine development timelines from years to months looks to be paying off. European Union countries that opt to buy doses would be allocated the shots on a pro rata population basis.

Health and Human Service Secretary Alex Azar told "CBS This Morning" on Friday that Pfizer's emergency use authorization application for its coronavirus vaccine candidate "means that hope and help are on the way".

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.